Announcements

MINDDS (Maximising Impact of Research in NeuroDevelopmental Disorders) 3 Open Day Meeting at Koç University Hospital, November 20,2019

Author: KUSOM

MINDDS (Maximising Impact of Research in NeuroDevelopmental Disorders) 3 Open Day Meeting at Koç University Hospital, November 20,2019 

 

Understanding rare neurodevelopmental disorders (NDD) has the potential drive for major new therapies for the common NDD of schizophrenia and Autism Spectrum Disorder (ASD).

 

NDD affect 1 in 25 individuals in Europe and have high impact on healthcare systems, economic development and society. Our key challenge is to link new knowledge from psychiatric genomics to identify neurobiological mechanisms that lead to NDD.

 

MINDDS focuses on NDD patients with rare pathogenic CNV, whose study have the potential to drive major new understanding and better therapies for all NDD, including the more common neuropsychiatric disorders of Autism Spectrum Disorder (ASD) and schizophrenia. Currently, lack of mechanistic knowledge hampers development of improved patient diagnosis and treatment.

 

MINDDS 3 Open day is a conference offered by the MINDDS COST Action to focus on research for patients, who have Neurodevelopmental Disorders (NDD) arising from possession of pathogenic Copy Number Variants (CNV) of high genetic penetrance. All interested participants are welcome to the meeting. For registration, please email hyapici@ku.edu.tr and bizgi@ku.edu.tr

 

Looking forward to seeing you at MINND3 Meeting!

 

Hale Yapici Eser